Abstract
Individual characteristics of prednisolone and cortisol pharmacokinetics in five young healthy subjects administered prednisolone in a single oral dose of 25 mg are described. The results suggests that prednisolone inhibits the glucocorticoid function of the adrenal cortex. It is concluded that the pharmacokinetics of prednisolone can be assessed from the reductions in serum cortisol concentration which it causes.
Similar content being viewed by others
References
M. Bazara and C. Shatty,Nonlinear Programming. Theory and Algorithms [in Russian], Moscow (1982).
A. P. Kulaichev,STADIA 4.5. Statistical Dialogue System. User's Manual [in Russian], Moscow (1991).
V. N. Solov'ev, A. A. Firsov, and V. A. Filov,Pharmacokinetics [in Russian], Moscow (1980).
B. M. Frey and F. J. Frey,Clin. Pharmacokinet.,19, 126–146 (1990).
F. J. Frey,J. Clin. Endocrinol. Metab.,21, 1076–1080 (1981).
F. J. Frey,Eur. J. Clin. Pharmacol.,21, 235–242 (1981).
J. G. Gambertoglio,J. Pharmacokinet. Biopharm.,8, 1–52 (1980).
P. M. Kabra,J. Chromatogr.,429, 155–176 (1988).
U. F. Legler,J. Clin. Endocrinol. Metab.,55, 762–767 (1982).
U. F. Legler,Atlas of Science: Pharmacology, No. 2, 345–350 (1988).
P. J. Meffin,Br. J. Clin. Pharmacol.,17, 395–404 (1984).
P. J. Morrison,Br. J. Clin. Pharmacol.,4, 597–603 (1977).
K. Oka,Clin. Chem.,36, 481–486 (1990).
L. Ost,Eur. J. Clin. Pharmacol.,26, 363–369 (1984).
U. Tauber,Int. J. Clin. Pharmacol. Ther. Toxicol.,22, 48–55 (1984).
Author information
Authors and Affiliations
Additional information
Translated fromByulleten' Eksperimental'noi Biologii i Meditsiny, Vol. 122, No. 7, pp. 51–54, July, 1996
Rights and permissions
About this article
Cite this article
Chekalin, A.F., Rossokhin, V.F. Pharmacokinetics of prednisolone and its impact on cortisol kinetics in the blood serum of apparently healthy human subjects. Bull Exp Biol Med 122, 695–697 (1996). https://doi.org/10.1007/BF02446026
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02446026